Introducing BrevagenPlus Test
At Marina Shores OB/GYN, I am pleased to be offer the BrevagenPlus test. This is a personalized breast cancer risk assessment test that predicts the risk of sporadic, estrogen receptor positive breast cancer. Clinical risk factors and genetic markers are combined to form an integrated risk.
Breast cancer is the second most common cancer among women in the United States. In fact, 1 in 8 women (12%) in the US will be diagnosed with breast cancer during her lifetime.
What are the risk factors for breast cancer?
There are certain risk factors that can increase your risk of developing breast cancer. These risk factors may include things you can change, such as diet and exercise, and things you cannot change, such as your gender and age.
Key risk factors for the most common type of breast cancer (sporadic or non hereditary breast cancer) include: a woman’s age, age at first period, age at first childbirth, history of breast biopsies, and family history of breast cancer.
When detected early, breast cancer has a high survival rate. That is why it is important to know your risk so that steps to reduce your risk or detect breast cancer early can be implemented.
What can I do to reduce the risk of developing breast cancer?
While many breast cancers cannot be prevented, there are things women can do that can reduce the risk of developing breast cancer, or increase the likelihood of early detection. By determining your risk using a Brevagenplus test, we can determine the breast cancer risk reduction and screening plan that is right for you.
How can BrevagenPlus help?
Brevagenplus is a cheek swab-based test that is collected in the office. No blood test is required.
Tags: cancer assessment